 Melanie Clair Macnicol
Concepts (179)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 12 | 2024 | 119 | 2.270 |
Why?
| | Nerve Tissue Proteins | 10 | 2021 | 191 | 1.700 |
Why?
| | Protein Biosynthesis | 9 | 2023 | 251 | 1.560 |
Why?
| | Pituitary Gland | 7 | 2025 | 89 | 1.230 |
Why?
| | Cell Cycle | 7 | 2019 | 226 | 0.760 |
Why?
| | Protein Processing, Post-Translational | 3 | 2024 | 154 | 0.750 |
Why?
| | Somatotrophs | 5 | 2025 | 39 | 0.730 |
Why?
| | Leptin | 6 | 2025 | 143 | 0.690 |
Why?
| | Stem Cells | 5 | 2021 | 171 | 0.630 |
Why?
| | RNA, Messenger | 10 | 2024 | 1097 | 0.620 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 964 | 0.610 |
Why?
| | Animals | 30 | 2025 | 13141 | 0.570 |
Why?
| | Cell Lineage | 3 | 2021 | 83 | 0.560 |
Why?
| | Neural Stem Cells | 1 | 2015 | 26 | 0.480 |
Why?
| | Cell Differentiation | 3 | 2019 | 648 | 0.470 |
Why?
| | Xenopus Proteins | 5 | 2019 | 26 | 0.460 |
Why?
| | Signal Transduction | 8 | 2025 | 1612 | 0.440 |
Why?
| | Receptors, Leptin | 3 | 2025 | 47 | 0.430 |
Why?
| | Transcription Factor Pit-1 | 4 | 2025 | 18 | 0.430 |
Why?
| | Oocytes | 7 | 2019 | 73 | 0.420 |
Why?
| | Growth Hormone | 4 | 2025 | 99 | 0.420 |
Why?
| | Growth and Development | 2 | 2018 | 14 | 0.400 |
Why?
| | Diet, High-Fat | 2 | 2024 | 214 | 0.390 |
Why?
| | Pituitary Gland, Anterior | 2 | 2021 | 35 | 0.360 |
Why?
| | Reproduction | 2 | 2021 | 56 | 0.360 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2010 | 41 | 0.360 |
Why?
| | Receptors, LHRH | 2 | 2021 | 12 | 0.330 |
Why?
| | 3' Untranslated Regions | 6 | 2021 | 52 | 0.330 |
Why?
| | Xenopus | 5 | 2011 | 37 | 0.320 |
Why?
| | Mice | 15 | 2025 | 5673 | 0.300 |
Why?
| | Cells, Cultured | 7 | 2021 | 1587 | 0.290 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2021 | 135 | 0.290 |
Why?
| | Gonadotrophs | 2 | 2023 | 18 | 0.260 |
Why?
| | Weight Gain | 2 | 2024 | 234 | 0.250 |
Why?
| | Phosphorylation | 2 | 2017 | 525 | 0.240 |
Why?
| | Ribonucleoproteins | 4 | 2019 | 16 | 0.240 |
Why?
| | Growth Hormone-Releasing Hormone | 2 | 2020 | 27 | 0.230 |
Why?
| | Ghrelin | 2 | 2020 | 29 | 0.230 |
Why?
| | Adipocytes | 2 | 2021 | 121 | 0.220 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 55 | 0.210 |
Why?
| | Malnutrition | 1 | 2024 | 86 | 0.210 |
Why?
| | Transcriptome | 1 | 2025 | 316 | 0.200 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2024 | 185 | 0.190 |
Why?
| | Pyrans | 1 | 2021 | 16 | 0.190 |
Why?
| | Prolactin | 2 | 2018 | 44 | 0.190 |
Why?
| | Receptors, Ghrelin | 1 | 2020 | 4 | 0.180 |
Why?
| | Hypothalamus | 1 | 2021 | 44 | 0.180 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2021 | 27 | 0.180 |
Why?
| | Endocrine System | 1 | 2020 | 16 | 0.180 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2021 | 77 | 0.180 |
Why?
| | Polyadenylation | 5 | 2019 | 19 | 0.180 |
Why?
| | Fasting | 1 | 2020 | 72 | 0.180 |
Why?
| | Humans | 13 | 2021 | 50201 | 0.180 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 100 | 0.180 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2019 | 5 | 0.170 |
Why?
| | Cell Cycle Proteins | 2 | 2012 | 166 | 0.160 |
Why?
| | Rats | 3 | 2021 | 3277 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2018 | 192 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-mos | 2 | 2012 | 7 | 0.150 |
Why?
| | Cell Line, Tumor | 3 | 2021 | 1390 | 0.150 |
Why?
| | Mice, Knockout | 4 | 2025 | 840 | 0.150 |
Why?
| | Protein Isoforms | 1 | 2017 | 118 | 0.140 |
Why?
| | Profilins | 1 | 2017 | 13 | 0.140 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 31 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2017 | 104 | 0.130 |
Why?
| | Female | 13 | 2025 | 26829 | 0.130 |
Why?
| | Spinal Cord | 1 | 2017 | 174 | 0.130 |
Why?
| | Obesity | 1 | 2023 | 1112 | 0.120 |
Why?
| | Plastics | 1 | 2014 | 10 | 0.120 |
Why?
| | Cell Line | 1 | 2017 | 1010 | 0.120 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 37 | 0.120 |
Why?
| | MAP Kinase Signaling System | 3 | 2012 | 118 | 0.120 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 121 | 0.120 |
Why?
| | Patch-Clamp Techniques | 1 | 2014 | 123 | 0.120 |
Why?
| | Nuclear Proteins | 2 | 2008 | 242 | 0.110 |
Why?
| | Flow Cytometry | 1 | 2016 | 475 | 0.110 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2012 | 15 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2021 | 1187 | 0.100 |
Why?
| | Male | 9 | 2024 | 25572 | 0.100 |
Why?
| | Xenopus laevis | 3 | 2019 | 37 | 0.090 |
Why?
| | Systems Integration | 1 | 2010 | 22 | 0.090 |
Why?
| | Animals, Newborn | 2 | 2024 | 367 | 0.090 |
Why?
| | RNA, Messenger, Stored | 1 | 2009 | 4 | 0.090 |
Why?
| | Neurons | 2 | 2014 | 455 | 0.080 |
Why?
| | Models, Biological | 2 | 2010 | 722 | 0.080 |
Why?
| | Brain | 1 | 2017 | 1311 | 0.080 |
Why?
| | Genes, mos | 1 | 2008 | 3 | 0.080 |
Why?
| | Thyrotropin | 2 | 2020 | 47 | 0.080 |
Why?
| | PC12 Cells | 1 | 2008 | 24 | 0.080 |
Why?
| | Subcellular Fractions | 1 | 2008 | 34 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 1782 | 0.080 |
Why?
| | Protein Transport | 1 | 2008 | 183 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2021 | 542 | 0.070 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2008 | 94 | 0.070 |
Why?
| | Time Factors | 2 | 2010 | 2909 | 0.060 |
Why?
| | Oogenesis | 2 | 2019 | 15 | 0.060 |
Why?
| | Homeodomain Proteins | 1 | 2025 | 86 | 0.060 |
Why?
| | Pituitary Hormones | 1 | 2024 | 18 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2008 | 987 | 0.060 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 136 | 0.060 |
Why?
| | Caloric Restriction | 1 | 2024 | 34 | 0.060 |
Why?
| | Lactation | 1 | 2024 | 59 | 0.060 |
Why?
| | Follicle Stimulating Hormone | 1 | 2023 | 39 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2023 | 302 | 0.050 |
Why?
| | MCF-7 Cells | 1 | 2021 | 62 | 0.050 |
Why?
| | Adipokines | 1 | 2021 | 10 | 0.050 |
Why?
| | Estrus | 1 | 2021 | 14 | 0.050 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 37 | 0.050 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2021 | 39 | 0.050 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 51 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2021 | 131 | 0.050 |
Why?
| | Blotting, Western | 3 | 2008 | 587 | 0.050 |
Why?
| | Mutation | 2 | 2020 | 1288 | 0.050 |
Why?
| | Testis | 1 | 2021 | 65 | 0.040 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2020 | 10 | 0.040 |
Why?
| | Receptors, Neuropeptide | 1 | 2020 | 11 | 0.040 |
Why?
| | Ovary | 1 | 2021 | 114 | 0.040 |
Why?
| | Drug Discovery | 1 | 2021 | 83 | 0.040 |
Why?
| | Cell Division | 1 | 2021 | 293 | 0.040 |
Why?
| | Cell Movement | 1 | 2021 | 245 | 0.040 |
Why?
| | Aging | 1 | 2004 | 674 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2021 | 369 | 0.040 |
Why?
| | Poly(A)-Binding Protein I | 1 | 2019 | 5 | 0.040 |
Why?
| | Proteins | 1 | 2002 | 348 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2023 | 763 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1029 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2004 | 781 | 0.040 |
Why?
| | Sex Factors | 1 | 2020 | 700 | 0.040 |
Why?
| | Progesterone | 2 | 2012 | 55 | 0.040 |
Why?
| | Neoplasms | 1 | 2008 | 1233 | 0.040 |
Why?
| | DNA Primers | 2 | 2008 | 207 | 0.040 |
Why?
| | Gene Deletion | 1 | 2018 | 267 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2017 | 81 | 0.030 |
Why?
| | Integrases | 1 | 2016 | 43 | 0.030 |
Why?
| | MicroRNAs | 1 | 2020 | 349 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2016 | 88 | 0.030 |
Why?
| | Pregnancy | 1 | 2024 | 2609 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 466 | 0.030 |
Why?
| | Pedunculopontine Tegmental Nucleus | 1 | 2014 | 24 | 0.030 |
Why?
| | Materials Testing | 1 | 2014 | 56 | 0.030 |
Why?
| | Membrane Potentials | 1 | 2014 | 117 | 0.030 |
Why?
| | Cell Count | 1 | 2014 | 147 | 0.030 |
Why?
| | Base Sequence | 2 | 2008 | 653 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2008 | 795 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2014 | 195 | 0.030 |
Why?
| | Cell Survival | 1 | 2014 | 590 | 0.030 |
Why?
| | Progestins | 1 | 2012 | 10 | 0.030 |
Why?
| | Oligonucleotides, Antisense | 1 | 2012 | 28 | 0.030 |
Why?
| | Mammals | 1 | 2012 | 57 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 1419 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2012 | 97 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 1581 | 0.020 |
Why?
| | Cyclin B2 | 1 | 2009 | 2 | 0.020 |
Why?
| | Cyclins | 1 | 2009 | 38 | 0.020 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2008 | 5 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2008 | 73 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 96 | 0.020 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2008 | 6 | 0.020 |
Why?
| | Species Specificity | 1 | 2008 | 191 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2008 | 236 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2004 | 45 | 0.020 |
Why?
| | Transcription Factors | 1 | 2008 | 563 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2004 | 153 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p107 | 1 | 2002 | 5 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2002 | 8 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 56 | 0.010 |
Why?
| | CDC2 Protein Kinase | 1 | 2002 | 16 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2002 | 110 | 0.010 |
Why?
| | Mitosis | 1 | 2002 | 88 | 0.010 |
Why?
| | Mutagenesis | 1 | 2002 | 60 | 0.010 |
Why?
| | Cytoplasm | 1 | 2002 | 91 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2002 | 111 | 0.010 |
Why?
| | Plasmids | 1 | 2002 | 164 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 732 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2002 | 173 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2002 | 183 | 0.010 |
Why?
| | RNA | 1 | 2002 | 166 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 579 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 378 | 0.010 |
Why?
|
|
Macnicol's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|